What question did this study set out to answer?

To assess the clinical significance of the C-reactive protein/albumin ratio in autoimmune encephalitis patients, focusing on its predictive ability.

February 5, 2026Open Access

C-reactive protein-to-albumin ratio predicts intensive care admission and disease severity in autoimmune encephalitis

Key Points

To assess the clinical significance of the C-reactive protein/albumin ratio in autoimmune encephalitis patients, focusing on its predictive ability.
Analyzed a retrospective cohort of 114 autoimmune encephalitis patients.
Measured serum C-reactive protein and albumin levels within 24 hours of admission.
Calculated the C-reactive protein/albumin ratio.
Assessed disease severity using the Clinical Assessment Scale for Autoimmune Encephalitis and modified Rankin Scale.
Employed statistical methods including logistic regression and ROC curve analysis.
Patients needing ICU admission had significantly higher CRP and CAR values.
CAR demonstrated stronger correlations with disease severity scores than CRP or albumin alone.
Logistic regression identified CAR, CRP, and albumin as independent predictors of ICU admission.
ROC analysis showed high predictive accuracy for CAR and CRP.

Abstract

Objective To evaluate the clinical relevance of the C-reactive protein/albumin ratio (CAR) in patients with autoimmune encephalitis (AE), with an emphasis on its predictive utility for disease severity, intensive care unit (ICU) admission, and functional outcomes. Methods A retrospective cohort of 114 patients with AE was analyzed. Serum C-reactive protein (CRP) and albumin (ALB) levels were measured within 24 hours of admission, and CAR was subsequently calculated. Disease severity was assessed using the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) and the modified Rankin Scale (mRS) at discharge. Statistical analyses included the Mann–Whitney U test, Spearman correlation, logistic regression, and receiver operating characteristic (ROC) curve analysis to evaluate associations with ICU admission, respiratory failure, and disability. Results Patients requiring ICU admission exhibited significantly elevated CRP levels (11.00 vs. 2.40 mg/L, p 0.001), reduced ALB levels (36.00 vs. 38.00 g/L, p = 0.029), and higher CAR values (0.282 vs. 0.064, p 0.001). Comparable patterns were observed in patients with respiratory failure and severe disability (mRS ≥ 3). CAR demonstrated stronger correlations with both CASE score at admission (r = 0.448, p 0.001) and mRS at discharge (r = 0.222, p = 0.018) than either CRP or ALB alone. Multivariate logistic regression analysis, adjusted for age, sex, CASE score, and other potential confounders, identified CAR (OR = 2.100; 95% CI: 1.151–3.831; p = 0.016), CRP (OR = 1.023; 95% CI: 1.004–1.042; p = 0.015), and ALB (OR = 0.875; 95% CI: 0.787–0.973; p = 0.013) as independent predictors of ICU admission. ROC curve analysis indicated high predictive accuracy for CAR (AUC = 0.835; cutoff = 0.125; sensitivity = 91.3%) and CRP (AUC = 0.820; cutoff = 4.35; sensitivity = 82.6%). Conclusion CAR represents a novel and readily accessible biomarker that outperforms CRP or ALB alone in predicting disease severity and the need for ICU care in patients with AE. Its incorporation into early clinical assessment protocols may enhance risk stratification and inform decisions regarding intensive care resource allocation.

Read Full Paperexternally

Ask AI

Helpful

Bookmark

View Full Paper